Viridian Therapeutics, Inc.\DE (VRDN) Inventory Average (2014 - 2016)
Viridian Therapeutics, Inc.\DE's (VRDN) quarterly Inventory Average came in at $63000.0 in Q4 2016, down 77.13% year-on-year from $275500.0 in Q1 2016, and down 54.18% quarter-over-quarter from $137500.0 in Q3 2016.
Viridian Therapeutics, Inc.\DE (VRDN) Inventory Average (2014 - 2016) Analysis & Trends
Viridian Therapeutics, Inc.\DE's Inventory Average history runs 3 years deep, the most recent figure standing at $63000.0 for Q4 2016.
- On a quarterly basis, Inventory Average fell 77.13% year-over-year to $63000.0 in Q4 2016; TTM through Dec 2016 was $63000.0, a 77.13% decrease from a year earlier, with the FY2016 full-year figure at $125500.0, down 31.42% from the prior year.
- Inventory Average eased to $63000.0 in Q4 2016 per VRDN's latest filing, from $137500.0 in the prior quarter.
- Across five years, Inventory Average topped out at $450000.0 in Q3 2015 and bottomed at $63000.0 in Q4 2016.
- The 3-year median for Inventory Average is $234500.0 (2016), against an average of $250063.4.
- Across the five-year window, Inventory Average soared 111.66% in 2015 and plunged 77.13% in 2016, its largest moves.
- Year by year, Inventory Average stood at $205532.0 in 2014, then surged by 34.04% to $275500.0 in 2015, then plunged by 77.13% to $63000.0 in 2016.
- Per Business Quant, the three latest VRDN Inventory Average figures stand at $63000.0 (Q4 2016), $137500.0 (Q3 2016), and $241000.0 (Q2 2016).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 644.91 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.73 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.15 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Viridian Therapeutics, Inc.\DE | 631.55 Mn | 631.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 63,000.00 |
| Sep 30, 2016 | 137,500.00 |
| Jun 30, 2016 | 241,000.00 |
| Mar 31, 2016 | 228,000.00 |
| Dec 31, 2015 | 275,500.00 |
| Sep 30, 2015 | 450,000.00 |
| Jun 30, 2015 | 433,000.00 |
| Mar 31, 2015 | 254,500.00 |
| Dec 31, 2014 | 205,532.00 |
| Sep 30, 2014 | 212,602.00 |